skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.10e (Release date: 2017-10-30)
SearchBox Top
SearchBox Bottom
Indium In 111 Girentuximab (Code C74047)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Indium In 111 Girentuximab

Definition: A radioimmunoconjugate comprised of the chimeric monoclonal antibody girentuximab conjugated with the gamma-emitting radioisotope indium In 111. Indium In 111 girentuximab binds to G250, allowing the localization of G250-expressing tumor cells using gamma scintigraphy. Found in the majority of renal cell carcinomas (RCCs), G250 or carbonic anhydrase isozyme IX (CA IX) is a cell surface tumor-associated antigen (TAA).

Label: Indium In 111 Girentuximab

NCI Thesaurus Code: C74047 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL383509  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
In-111 MoAbG250
Indium In 111 Girentuximab

External Source Codes: 
PDQ Closed Trial Search ID 588355
PDQ Open Trial Search ID 588355 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C74047
Legacy_Concept_Name Indium_I_111_Chimeric_Monoclonal_Antibody_G250
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Indicator, Reagent, or Diagnostic Aid

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom